The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday preview: Vote in Parliament, GlaxoSmithKline in focus

Tue, 29th Oct 2019 15:24

(Sharecast News) - The market spotlight on Wednesday will continue to be very much on Brexit, with investors keen to find out what Parliament voted the night before regarding the timing of the upcoming general elections.
But even if the opposition manages to clinch an earlier date than what the government was pushing for, any reaction from traders might be limited ahead of the US central bank's interest rate decision scheduled for after the close of markets.

Fed funds futures have fully priced-in a 25 basis point reduction in the target range for official short-term interest rates from 1.75-2.0% to 1.5-1.75%.

But some economists still se the Federal Reserve holding fire, meaning that there was room for some investors to be left disappointed.

In the background, US consultancy ADP is set to publish its private sector payrolls report for October at 1215 GMT, followed by a preliminary third quarter gross domestic product a quarter of an hour afterwards.

Across the Channel meanwhile, readings are due out on German unemployment in October and surveys of euro area consumer and industrial confidence for the same month.



On the corporate side of things, and for GlaxoSmithKline, analysts at Deutsche Bank were anticipating an approximately 3.0% rise in group sales for the third quarter at constant exchange rates.

Vaccine sales were seen growing by roughly 11.0% CER, helped by sales of Shingrix and early deliveries of its flu vaccines.

Sales at its consumer arm were seen up by 3.0% CER but down by 1.0% on the pharma side of the business.

Margins meanwhile were seen 270 basis points lower year-on-year following its purchase of Tesaro and due to the impact of its CHC joint venture, which combined would result in a 6.0% drop in earnings per share on a CER basis.

Wednesday 30 October

INTERIM DIVIDEND PAYMENT DATE

Essentra, Shore Capital Group Ltd., Smith & Nephew, Trans-Siberian Gold, Xpediator

QUARTERLY PAYMENT DATE

Marble Point Loan Financing Limited NPV

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Business Climate Indicator (EU) (10:00)

Consumer Confidence (EU) (10:00)

Crude Oil Inventories (US) (14:30)

Economic Sentiment Indicator (EU) (10:00)

GDP (Preliminary) (US) (12:30)

Industrial Confidence (EU) (10:00)

MBA Mortgage Applications (US) (11:00)

Services Confidence (EU) (10:00)

Unemployment Rate (GER) (08:55)

Q3

Smurfit Kappa Group

FINALS

Leaf Clean Energy Co (DI)

EGMS

ADES International Holding (DI)

AGMS

Angle, Ashoka India Equity Investment Trust, Frontier Developments, Goldplat, Hargreaves Services, Ideagen, Pantheon International , Redde, Sensyne Health

UK ECONOMIC ANNOUNCEMENTS

BRC Shop Price Index (00:01)

Nationwide House Price Index (07:00)

FINAL DIVIDEND PAYMENT DATE

Haynes Publishing Group

FINAL EX-DIVIDEND DATE

North Atlantic Smaller Companies Inv Trust
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.